Literature DB >> 12109390

Hepatitis B prevalence and risk factors for HBsAg carriage amongst Somali households in Liverpool.

D Aweis1, B J Brabin, N J Beeching, J E Bunn, C Cooper, K Gardner, C Iriyagolle, C A Hart.   

Abstract

The prevalence of hepatitis B core antibody (anti-HBc) and surface antigen (HBsAg) in the Somali population in Liverpool is described and groups who may benefit from vaccination are identified. A cross-sectional descriptive study was undertaken. A total of 439 subjects, aged between 10 months and 80 years, from 151 households, were screened for anti-HBc and HBsAg. One hundred ninety-four (44.2%) were children aged less than 15 years. Three hundred and nine (69%) of enrolled subjects were born in Somalia, 122 (27.2%) were born in the UK and 8 were born elsewhere. Of the study population, 5.7% were carriers of HBsAg, with the highest prevalence in adults aged 20 to 44 years (9.4%). A history of circumcision (RR 95% CI; 1.2, 1.1-1.5) was the most significant risk factor for HBsAg carriage, but was not significant on multivariate analysis. Prevalence of anti-HBc was 27.5%, and increased with age over the first four decades. Univariate analysis showed that a history of living in a refugee camp (RR 95% CI; 3.1, 1.7-5.7), receiving an injection in Somalia (2.1, 1.7-2.5), a history of circumcision or other surgical procedure in Somalia (1.4, 1.3-1.6) and being born in Somalia (1.3, 1.2-1.4) were significant risk factors for anti-HBc positivity. On multivariate analysis, only circumcision (OR 95% CI; 4.3, 1.8-10.3) and receiving an injection in Somalia (2.5, 1.5-4.4) remained significant. Seven of 80 (8.7%) children born in the UK and aged five years or less had evidence of exposure to hepatitis B, of whom only one had a close family member identified to be HBsAg seropositive. Previous infection with hepatitis B is common in this population. Horizontal transmission may be continuing at an early age within the UK, suggesting a population of at risk individuals who would benefit from surveillance and immunisation. Community circumcision is a risk factor for hepatitis B transmission and best practice should be followed when this procedure is undertaken.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12109390

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  12 in total

1.  Hepatitis B immunisation in Britain: time to change?

Authors:  Jangu Banatvala; Pierre Van Damme; Nedret Emiroglu
Journal:  BMJ       Date:  2006-04-08

2.  Communicable and non-communicable diseases among recent immigrants with implications for primary care; a comprehensive immigrant health approach.

Authors:  Ramin Asgary; Ramesh Naderi; Kristin A Swedish; Clyde L Smith; Blanca Sckell; Sara Doorley
Journal:  J Immigr Minor Health       Date:  2011-12

3.  Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma.

Authors:  Abdirashid M Shire; Dalbir S Sandhu; Joseph K Kaiya; Abdul M Oseini; Ju Dong Yang; Roongruedee Chaiteerakij; Teresa A Mettler; Nasra H Giama; Rosebud O Roberts; Terry M Therneau; Gloria M Petersen; Keith L Knutson; Lewis R Roberts
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

Review 4.  Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.

Authors:  Claus Niederau
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 5.  An audit of neonatal and infant hepatitis B immunisation and serological testing in two counties of England, 2007-12.

Authors:  Charles Richard Beck; Vanessa MacGregor; Sophia Makki; Richard Puleston
Journal:  J Infect Prev       Date:  2014-09

6.  Informing the design of a national screening and treatment programme for chronic viral hepatitis in primary care: qualitative study of at-risk immigrant communities and healthcare professionals.

Authors:  Lorna Sweeney; John A Owiti; Andrew Beharry; Kamaldeep Bhui; Jessica Gomes; Graham R Foster; Trisha Greenhalgh
Journal:  BMC Health Serv Res       Date:  2015-03-13       Impact factor: 2.655

7.  Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries.

Authors:  Amena A Ahmad; Abby M Falla; Erika Duffell; Teymur Noori; Angela Bechini; Ralf Reintjes; Irene K Veldhuijzen
Journal:  BMC Infect Dis       Date:  2018-01-11       Impact factor: 3.090

8.  Low hepatitis B testing among migrants: a cross-sectional study in a UK city.

Authors:  Iro Evlampidou; Matthew Hickman; Charles Irish; Nick Young; Isabel Oliver; Sophie Gillett; Alexandra Cochrane
Journal:  Br J Gen Pract       Date:  2016-03-29       Impact factor: 5.386

9.  Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England.

Authors:  M A Balogun; J V Parry; K Mutton; C Okolo; L Benons; H Baxendale; T Hardiman; E H Boxall; J Sira; M Brown; S Barnett; U Gungabissoon; A Williams; D A Kelly; S Vijeratnam; S Ijaz; B Taylor; C G Teo; M E Ramsay
Journal:  Epidemiol Infect       Date:  2012-07-31       Impact factor: 4.434

Review 10.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.